Uncategorised - European Medical Journal

Transplanting Hepatitis C-infected Livers Is Safe and Cost-effective

Analysis of a large registry has shown hepatitis C (HCV)-positive livers to be safe for transplant, since the transplanted disease is controlled by…

Perinatal Hepatitis C Linked to Earlier Cirrhosis Development

Hepatitis C virus (HCV) infection during the perinatal period leads to the earlier development of cirrhosis, suggests new research from Birmingham…

Advancements and Trends in Urology

EMJ Urology Editorial Board member Dr Alan Wein has enjoyed a long and distinguished career in healthcare, having been at the heart of numerous…

Pelvic Floor Exercises and Overactive Bladder

Pelvic floor muscle (PFM) training is commonly used to control overactive bladder, which is a very common form of urinary incontinence. The results of a…

New Genes Linked to Prostate Cancer

Prostate cancer is considered a major health concern, with >1 million new cases diagnosed every year and the disease claiming 300,000 lives each year…

INet NYC: Support for International Scientists

This interview is with Jess Sharrock, Social Media Manager at International Networking in New York City (INet NYC), New York, USA, an organisation that…

The European Medical Journal Presents: EMJ 3.4

Detailing a myriad of fascinating topics inside, the multidisciplinary publication, EMJ 3.4, is now available.

The Lancet Asthma Commission: Towards the Abolition of Asthma?

The more widespread use of inhaled corticosteroids (ICS) for the treatment of asthma following guideline recommendations 27 years ago1,2 delivered huge…

Translating Knowledge of IL-23 Targeting into New Solutions for Psoriasis Treatment

Following a brief introduction by Prof Lambert, the symposium started with an in-depth review of the current unmet needs in the clinical management of…

Type 2 Inflammation and the Evolving Profile of Uncontrolled Persistent Asthma

The objective of this symposium was to provide an overview of Type 2 inflammation in asthma. The speakers covered the pathophysiology of Type 2 asthma, its heterogeneity and the associated economic burden.